Intelligence Platform
Patents
Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7829533
Cyclosporin analog formulations
granted patentUS 7538189
Methods of making deuterated cyclosporin analogs
granted patentUS 7521421
Deuterated cyclosporine analogs and methods of making the same
granted patentUS 7429562
Cyclosporin analog formulations
granted patentUS 7358229
Deuterated cyclosporin analogs and their use as immunomodulating agents
granted patentUS 7332472
Cyclosporine analogue mixtures and their use as immunomodulating agents
granted patentUS 7160867
Rapamycin carbohydrate derivatives
granted patentUS 7141648
Synthesis of cyclosporin analogs
granted patentUS 7118919
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic
granted patentUS 7060672
Cyclosporin analog formulations
granted patentUS 6998385
Cyclosporine analogue mixtures and their use as immunomodulating agents
expired patentUS 6878550
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic
expired patentUS 6780995
Activated iododerivatives for the treatment of cancer and aids
expired patentUS 6686454
Antibodies to specific regions of cyclosporine related compounds
expired patentUS 6613739
Deuterated cyclosporine analogs and their use as immunomodulating agents
expired patentUS 6605593
Deuterated cyclosporine analogs and their use as immunomodulating agents
expired patentUS 6602715
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic
expired patentUS 6599750
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic
expired patentUS 6511988
Activated iododerivatives for the treatment of cancer and aids
expired patentUS 6503921
Deuterated rapamycin compounds, methods and uses thereof
expired patentUS 6468802
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic
expired patentUS 6461870
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic
expired patentUS 6342507
Deuterated rapamycin compounds, method and uses thereof
expired